Carolinas Wealth Consulting’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-154
Closed -$22.7K 169
2025
Q1
$22.7K Hold
154
﹤0.01% 445
2024
Q4
$25K Hold
154
﹤0.01% 445
2024
Q3
$25.1K Hold
154
﹤0.01% 456
2024
Q2
$21K Hold
154
﹤0.01% 473
2024
Q1
$23.6K Sell
154
-13,725
-99% -$2.05M ﹤0.01% 464
2023
Q4
$49.1K Buy
13,879
+150
+1% +$20K 0.01% 339
2023
Q3
$25.2K Sell
13,729
-91
-0.7% -$13.8K 0.01% 400
2023
Q2
$43.9K Buy
13,820
+55
+0.4% +$8.87K 0.01% 367
2023
Q1
$35K Buy
13,765
+6
+0% +$900 0.01% 412
2022
Q4
$31.7K Buy
13,759
+12
+0.1% +$1.7K 0.01% 416
2022
Q3
$29K Sell
13,747
-2
-0% -$289 0.01% 394
2022
Q2
$30K Buy
13,749
+13,619
+10,476% +$1.95M 0.01% 399
2022
Q1
$18K Sell
130
-57
-30% -$8.73K ﹤0.01% 501
2021
Q4
$33K Buy
187
+17
+10% +$2.83K 0.01% 418
2021
Q3
$28K Hold
170
0.01% 417
2021
Q2
$31K Hold
170
0.01% 425
2021
Q1
$33K Buy
170
+66
+63% +$12.7K 0.01% 427
2020
Q4
$21K Buy
104
+95
+1,056% +$19.7K 0.01% 470
2020
Q3
$2K Buy
9
+4
+80% +$891 ﹤0.01% 684
2020
Q2
$1K Buy
+5
New +$999 ﹤0.01% 547

Other funds holding CLX

Carolinas Wealth Consulting's CLX Position: Q2 2025 in Review

Carolinas Wealth Consulting sold out of Clorox (CLX) in Q2 2025, closing a stake of 154 shares — an estimated $22.7K sold.

Carolinas Wealth Consulting first reported a position in CLX in Q2 2020 and held it in 20 quarters. The position peaked at $49.1K in Q4 2023. 1,125 funds tracked by Wall St. Rank hold CLX as of Q2 2025.

  • Carolinas Wealth Consulting reported no remaining Clorox position as of Q2 2025 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 154 Clorox shares in Q2 2025, an estimated $22.7K.
  • Carolinas Wealth Consulting first reported a position in Clorox in Q2 2020 and held it in 20 quarters.
  • Carolinas Wealth Consulting's Clorox position peaked at $49.1K in Q4 2023.
  • 1,125 funds tracked by Wall St. Rank held Clorox as of Q2 2025.

Based on Carolinas Wealth Consulting's 13F filing for Q2 2025.